KR100561780B1 - Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients - Google Patents

Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients Download PDF

Info

Publication number
KR100561780B1
KR100561780B1 KR1019990034915A KR19990034915A KR100561780B1 KR 100561780 B1 KR100561780 B1 KR 100561780B1 KR 1019990034915 A KR1019990034915 A KR 1019990034915A KR 19990034915 A KR19990034915 A KR 19990034915A KR 100561780 B1 KR100561780 B1 KR 100561780B1
Authority
KR
South Korea
Prior art keywords
extract
tanza
cosmetic compositions
effective ingredients
sample
Prior art date
Application number
KR1019990034915A
Other languages
Korean (ko)
Other versions
KR20010018805A (en
Inventor
양재찬
윤명석
경기열
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1019990034915A priority Critical patent/KR100561780B1/en
Publication of KR20010018805A publication Critical patent/KR20010018805A/en
Application granted granted Critical
Publication of KR100561780B1 publication Critical patent/KR100561780B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 유효성분으로서 항자극 효과가 우수한 탱자 추출물을 함유하는 화장료 조성물에 관한 것으로서 본 발명의 유효성분인 탱자 추출물은 0.001-20.0중량부의 양으로 포함된다.The present invention relates to a cosmetic composition containing a tanza extract with excellent anti-irritant effect as an active ingredient, the tanza extract is an active ingredient of the present invention is included in an amount of 0.001-20.0 parts by weight.

Description

탱자 추출물을 함유하는 항자극용 화장료 조성물{COSMETIC COMPOSITIONS FOR ANTI-IRRITATION CONTAINING PONCIRI FRUCTUS EXTRACTS AS EFFECTIVE INGREDIENTS}Cosmetic composition for anti-irritant containing a tanza extract {COSMETIC COMPOSITIONS FOR ANTI-IRRITATION CONTAINING PONCIRI FRUCTUS EXTRACTS AS EFFECTIVE INGREDIENTS}

본 발명은 항자극용 화장료 조성물에 관한 것으로서 좀더 상세하게는 유효성분으로서 탱자 추출물을 함유하므로서 항자극 효과가 우수한 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for anti-irritant, and more particularly, to a cosmetic composition having excellent anti-irritant effect by containing a tanza extract as an active ingredient.

화장품은 피부를 보호하고 미화 청결을 위해 사용되는 제품이지만 화장품 조성물을 자세하게 살펴보면 본래의 피부 보호 목적과는 상이한 성분들이 제품형성에 필수 불가결한 존재로서 사용된다. 예를 들면 가용화제 및 유화제, 방부제, 향료 자외선 차단제 및 기타 효능, 효과를 부여하기 위해 쓰여지는 여러가지 부가물을 들 수 있다. 이러한 성분들은 일반적으로 피부에 염증이나, 뾰루지, 부종 등을 유발하는 주원인으로 알려져 있다.Cosmetics are products used to protect the skin and cleanse beautification, but if you look closely at the cosmetic composition, ingredients different from the original skin protection purposes are used as essential to the formation of the product. Examples include solubilizers and emulsifiers, preservatives, fragrance sunscreens and other additives used to impart other efficacy and effects. These ingredients are generally known to be the main causes of inflammation, rashes and edema in the skin.

염증은 세포나 조직이 어떠한 원인에 의해 손상을 받으면 그 반응을 최소화하고 손상된 부위를 원상으로 회복시키려는 일련의 방어 목적으로 나타나는 것이며 염증을 유발하는 원인으로 외상, 화상, 동상, 방사능 등에 의한 물리적 요인과 산(acid)과 같은 화학물질에 의한 화학적 요인 및 항체 반응에 의한 면역학적 요인들이 있으며 그 외에 혈관이나 호르몬 불균형에 의해서도 일어난다. 염증을 소실 시키기 위해 염증원의 제거, 생체반응 및 증상을 감소시키는 작용을 하는 것을 항염제라 한다.Inflammation is a series of defenses aimed at minimizing the response of a cell or tissue to any damage and restoring the damaged area to its original state. Inflammation is the cause of inflammation, including physical factors such as trauma, burns, frostbite, and radiation. There are chemical factors caused by chemicals such as acids and immunological factors caused by antibody reactions. They can also be caused by vascular or hormonal imbalances. Anti-inflammatory drugs are called anti-inflammatory drugs that work to reduce inflammation, reduce biologic reactions and symptoms in order to eliminate inflammation.

화장품에 있어서 피부 부작용 유발요인은 항상 잠재되어 있으며 이를 해결하고자 여러가지 연구가 진행되어 왔으며 현재까지 항염의 목적으로 이용되고 있는 물질로는 비스테로이드계로 프루폐나믹산(flufenamic acid), 이부프로펜(ibuprofenThe cause of skin side effects in cosmetics is always latent, and various studies have been conducted to solve this problem. Until now, the substance used for the purpose of anti-inflammatory is nonsteroidal flufenamic acid and ibuprofen.

), 벤지다민(benzydamine), 인도메타신(indometacine)등이 있고, 스테로이드 계통으로 프레드니솔론(prednisolone), 덱사메타손(dexamethasone)등이 있으며(김창종, 병태생리학, 한림상사, p61-69, 1988), 알란토인, 아즈렌, ε-아미노키프론산, 하이드로코티존(v), 감초산 및 그 유도체(β-글리칠레친산, 글리칠레친산유도체)등이 항염증에 효과가 있는 것으로 알려져 있으나(광정무부, 신화장품학, 남산당, p162, 1993), 인도메타신은 화장료에는 사용할 수 없는 물질이고 하이드로코티존은 사용량이 제한되어 있으며, 감초산 및 그 유도체는 안정화 시키기 어렵거나 용해도가 좋지않아 실제 적용시 농도의 제한으로 인하여 실질적인 효과를 거두기가 어려운 점이 있는 등 지금까지 알려진 항염제는 피부안전성 면이나 화장료 배합시의 안정성면에서 대부분 문제점을 가지고 있어서 그 사용이 제한되고 있다.), Benzydamine, indometacine, and predisolone, dexamethasone, etc. (Kim Chang-jong, Pathophysiology, Hallym Co., p61-69, 1988), allantoin , Azulene, ε-aminokiproic acid, hydrocortisone (v), licorice acid and its derivatives (β-glycileic acid, glycylinic acid derivatives) are known to be effective in anti-inflammatory. , Namsan Sugar, p162, 1993), indomethacin is a substance that cannot be used in cosmetics, and hydrocortisone has a limited amount of use. Licorice acid and its derivatives are difficult to stabilize or have poor solubility. The anti-inflammatory drugs known to date have a problem in terms of skin safety and stability in formulating cosmetics. Its use is limited.

이에 본 발명자들은 상기와 같은 단점을 극복하고자 예의 연구한 결과 탱자 추출물이 피부에 대한 안전성이 우수하며 화장료 배합시 보존안정화가 쉽고 실질적 으로도 효과가 있다는 것을 발견하여 본 발명을 완성하였다.Accordingly, the present inventors have completed the present invention by finding that the tanza extract is excellent in safety for the skin and easy to stabilize the preservation when formulating cosmetics, and has a substantial effect.

따라서, 본 발명은 유효성분으로서 탱자 추출물을 함유하는 항자극용 화장료 조성물을 제공함을 목적으로 한다.Therefore, an object of the present invention is to provide an anti-irritant cosmetic composition containing a tanza extract as an active ingredient.

탱자나무(Poncirus trifoliata Rafin)는 경기도 이남에서 자라는 낙엽관목으로서 높이가 3~5 센티미터의 굳센 가시가 호생한다. 잎은 호생하며 3 출엽으로서 엽병에 날개가 약간 있고 소엽은 혁질이며 도란형 또는 타원형이고 둔두 또는 미오목두이며 예저이고 길이 25 밀리미터이다. 꽃은 5월에 피고 백색이며 정생 또는 액생하고 1개 또는 2개씩 달리며 꽃받침잎과 꽃잎은 5개가 이생하고 수술은 많으며 자방에 밀모가 있다. 열매는 둥글고 지름 3 센티미터로서 향기가 좋으나 먹을 수 없으며 9월에 익고 종자는 긴 타원형으로서 길이가 1~1.3 센티미터이다. 열매를 약용으로 하며 묘목은 귤나무의 대목으로 사용하고 성목은 남부지방에서 산울타리로 환영을 받고 있다(대한식물도감. 이창복. 경문사. 1993).The Pancirus trifoliata Rafin is a deciduous shrub that grows south of Gyeonggi-do and has a strong spine of 3 to 5 centimeters in height. The leaves are regenerated, 3 leaflets, with some wings on the petiole, the lobules are stalk, obovate or oval, blunt or myo-headed, basal, 25 mm long. Flowers bloom in May, white, perennial or animate, and run one or two. The calyx leaves and petals are 5 biphytes, many stamens, and purple. Fruits are round, 3 centimeters in diameter, good in scent, but inedible, ripen in September, and seeds are long oval, 1-1.3 centimeters long. The fruit is medicinal, the seedling is used as the tree of the tangerine tree, and the sapling is welcomed as a hedge in the south (Korea Plant Book. Lee Chang-bok. Kyungmunsa, 1993).

탱자나무의 어린 열매를 햇볕에 말린 것을 지실(PONCIRI FRUCTUS)이라고 하며 함유된 주요성분은 비타민 C 및 네오헤스페리딘(neohesperidin), 나리진(nargin), 로이폴린(rhoifolin)등의 플라보노이드 배당체와 메틸티라민(m-methyl tyramine)이 함유되어 있으며, 예로부터 한방에서는 건위, 이담, 이수, 산치 등에 효능이 있는 것으로 알려져 있으며, 소화불량, 변비, 위통, 자궁수축, 탈항의 치료에 이용되어 왔다.PONCIRI FRUCTUS is the dried fruit of the tangerine tree, and its main ingredients are vitamin C and flavonoid glycosides such as neohesperidin, nargin, and rhoifolin, and methyltyramine ( m-methyl tyramine), which is known to be effective in dry stomach, edema, diarrhea, and acid value in traditional Korean medicine, and has been used for the treatment of indigestion, constipation, stomach pain, uterine contractions and disinfection.

본 발명에 사용된 탱자 추출물을 얻는 방법은 다음과 같다.The method of obtaining the tanza extract used in the present invention is as follows.

먼저 탱자 1킬로그램을 깨끗이 세척하고, 여기에 정제수 3.5 킬로그램과 1,3-부틸렌글리콜 또는 에탄올 1.5 킬로그램을 첨가하여 1~2주 동안 추출한 후 여과하므로서 3 킬로그램의 추출물을 얻었다. 본 발명에 있어서 하기의 모든 실험예 및 실시예에서는 1,3-부틸렌글리콜로 추출한 시료를 사용하였다. First, one kilogram of tanza was washed, and 3.5 kilograms of purified water and 1.5 kilograms of 1,3-butylene glycol or ethanol were added thereto, followed by extraction for 1 to 2 weeks, followed by filtration to obtain an extract of 3 kilograms. In the present invention, all the following Experimental Examples and Examples used samples extracted with 1,3-butylene glycol.

본 발명의 탱자 추출물은 화장료 조성물 총중량에 대해서 0.001중량부-20중량부의 범위로 사용하는 것이 바람직한데 탱자 추출물이 0.001중량부 이하일 경우에는 기대하는 정도의 효과에 미치지 못했으며 20중량부 이상에서는 제품에 배합시 색상 및 냄새, 사용성을 고려할 때 문제점이 발생되었다.The tanza extract of the present invention is preferably used in the range of 0.001 parts by weight to 20 parts by weight relative to the total weight of the cosmetic composition, but when the tanza extract is less than 0.001 parts by weight, it does not meet the expected effect and at least 20 parts by weight of the product Problems occurred when considering the color, smell and usability in the formulation.

본 발명의 탱자 추출물에 대한 세포독성, 알러지, 항염증 및 피부 1차 자극성 평가실험을 하기와 같이 실시하였다.Cytotoxicity, allergy, anti-inflammatory and skin primary irritation evaluation experiment for the tanza extract of the present invention was carried out as follows.

실험 1. 세포독성시험Experiment 1. Cytotoxicity Test

본 추출물에 대한 세포독성을 알아보기 위하여 V79-4세포[Chinese Hamster, CCL(continuous cell line:연속세포주)의 폐조직 섬유아세포]를 배양하여 MTT[3-(4,5-디메틸에틸티아졸-2-일)-2,5-디페닐테트라졸륨 브로마이드 환원 시험]법을 수행하고 MTT-포르마잔 생성물을 이소프로필알코올로 추출하여 570㎚에서 흡광도를 측정하였다. 각각의 물질에 대한 IC50을 알기 위하여 물질을 배지에 10.0%, 5.0%, 1.0%...로 희석하여 24시간 배양하여 IC50을 구하였다. 그 결과를 표 1에 나타내었다.To examine the cytotoxicity of the extract, cultured V79-4 cells [Chinese Hamster, CCL (continuous cell line), and lung tissue fibroblasts] 2-yl) -2,5-diphenyltetrazolium bromide reduction test] was performed and the MTT-formazan product was extracted with isopropyl alcohol to measure absorbance at 570 nm. In order to know the IC 50 for each material, the material was diluted in 10.0%, 5.0%, 1.0% ... in the medium and incubated for 24 hours to obtain an IC 50 . The results are shown in Table 1.

탱자 추출물의 세포독성 시험결과Cytotoxicity test results of tanza extract 시 료sample IC50(%, W/V)IC 50 (%, W / V) 소듐라우릴설페이트(SLS) 탱자 추출물Sodium Lauryl Sulfate (SLS) Tangza Extract 0.0025 >5.00.0025> 5.0

탱자 추출물은 소디움라우릴설페이트에 비하여 2000배 이상 세포독성이 낮게 나타나 안전성이 우수한 추출물임을 확인하였다.The tanza extract showed more than 2000 times lower cytotoxicity than sodium lauryl sulfate, indicating that the extract was excellent in safety.

실험 2. 알러지 평가Experiment 2. Allergy Assessment

본 추출물에 대한 알러지 유발여부를 확인하기 위하여 3일동안 하루 한번씩 시료를 마우스 귀에 25㎕씩 도포하여 4일째 임파절을 떼어내어 임파구를 분리 후 5% 이산화탄소 배양기에서 24-48시간 배양한 후 증폭정도를 방사선 동위원소 [3H]-메칠티미딘의 삽입량으로 측정한다. 국부임파절평가(LLNA:local lymph node assay)결과는 대조군에 비해 시료군의 임파구 증폭정도로 나타내며 한 농도에서라도 시료의 증폭정도(S.I:stimulation index)가 3배 이상이고 농도별로 증가하는 경향을 보일 경우 알러젠으로 간주하였다.To confirm the allergy to the extract, apply 25 μl of the sample to the mouse ear once a day for 3 days, remove the lymph node on the 4th day, isolate the lymphocytes, and incubate 24-48 hours in a 5% carbon dioxide incubator. The amount of radioisotope [ 3 H] -methylthymidine is measured. The local lymph node assay (LLNA) results indicate the lymphocyte amplification of the sample group compared to the control group, and allergens when the amplification degree (SI) of the sample is more than three times higher and the concentration tends to increase with each concentration. Considered as.

탱자 추출물의 알러지 평가 결과Allergy evaluation result of tanza extract 시 료sample 농도(%)density(%) 평균 cpmAverage cpm 증폭정도(S.I)Amplification degree (S.I) 에탄올 탱자 추출물 탱자 추출물Ethanol tanza extract tanza extract 60 50 10060 50 100 2973 2132 20112973 2132 2011 - 0.7 0.7-0.7 0.7

※-cpm(counter per minute): [3H]-메칠티미딘이 세포 내로 삽입되는 양※ -cpm (counter per minute): [ 3 H] -methylthymidine is inserted into the cell

-S.I(stimulation index) : 시료의 평균 cpm을 대조군의 평균 cpm으로  S.I (stimulation index): the mean cpm of the sample to the mean cpm of the control

나눈 값                            Divided by

표 2에서 보는 바와같이 본 발명의 탱자 추출물은 증폭정도(S.I)가 3이하로 서 알러지 유발 가능성이 거의 없는 것으로 나타났다.As shown in Table 2, the tanza extract of the present invention was found to have almost no allergic potential as the amplification degree (S.I) is 3 or less.

실험 3. 항염증 실험Experiment 3. Anti-inflammatory Experiment

본 추출물에 대한 항염증 효과를 알아보기 위하여 쥐 20마리를 각 5마리씩 탱자 추출물 1.0%와 3.0%를 처리하는 시료군과 인도메타신(Indomethacin) 1.0%를 처리하는 비교군 그리고 아리키돈산(Arachidonic acid)만을 처리하는 대조군으로 나누어 실험을 실시하여 쥐 귀두께의 평균치를 측정하였다. 탱자 추출물을 처리하는 시료군과 인도메타신을 처리하는 비교군은 시료를 20㎕/ear로 1일 1회 4일간 지속적으로 도포하였으며 아라키돈산만을 처리하는 대조군은 1일 1회 4일간 용매인 동량의 에탄올만 도포한 후 마지막 도포 1시간 후 모든 군에 아라키돈산을 2㎎/ear로 도포하여 인위적으로 쥐 귀에 부종을 유도하고 1시간 후 귀의 부종(ear edema) 정도를 마이크로미터를 사용하여 시료군과 비교군 그리고 대조군의 쥐 귀를 3회씩 반복 측정하여 귀두께의 변화를 기록하였다. 항염효과는 아라키돈산만을 처리한 대조군을 기준으로 부종억제 정도로 판정 하였다. 그 결과를 표 3에 나타내었다.To examine the anti-inflammatory effects of the extract, 20 rats of 5 rats were treated with 1.0% and 3.0% tanza extracts, a comparative group treated with 1.0% of indomethacin, and arachidonic acid. ) Was divided into the control group treated only to determine the average value of the mouse ear thickness. In the sample group treated with the tanza extract and the comparative group treated with indomethacin, the sample was continuously applied once a day for 4 days at 20 μl / ear, and the control group treated with only arachidonic acid was used for the same amount of solvent once a day for 4 days. After only one ethanol application, 1 hour after the last application, arachidonic acid was applied to all groups at 2 mg / ear to artificially induce edema in rat ears, and after 1 hour, the degree of ear edema was measured using a micrometer. The change in ear thickness was recorded by repeatedly measuring the rat ears of the control group and the control group three times. Anti-inflammatory effect was determined as the degree of edema inhibition based on the control group treated with arachidonic acid only. The results are shown in Table 3.

국소적용에 의한 귀두께 및 염증억제율Ear thickness and inflammation inhibition rate by topical application 시 료sample 농도(%)density(%) 아라키돈산 처리 전 귀두께(㎛)Ear thickness (㎛) before arachidonic acid treatment 아라키돈산 처리 후 귀두께(㎛)Ear thickness (㎛) after arachidonic acid treatment 억제율(%)% Inhibition 시료군Sample group 탱자 추출물 탱자 추출물Tanza extract tanza extract 1.0 3.01.0 3.0 275 288275 288 466 453466 453 25.1 30.225.1 30.2 비교군Comparison 인도메타신Indomethacin 1.01.0 288288 422422 46.646.6 대조군Control 아라키돈산Arachidonic acid 2㎎/ear2mg / ear 294294 549549 --

※ 억제율(%)=(A-B)/A×100※ Inhibition rate (%) = (A-B) / A * 100

A: 대조군 쥐 귀의 두께변화A: thickness change of control rat ear

(아라키돈산 처리후 귀의 두께-아라키돈산 처리전 귀의 두께)  (Thickness of ears after arachidonic acid treatment-thickness of ears before arachidonic acid treatment)

B: 시료군 쥐 귀의 두께변화B: Change in thickness of rat ear of sample group

(아라키돈산 처리후 귀의 두께-아라키돈산 처리전 귀의 두께)  (Thickness of ears after arachidonic acid treatment-thickness of ears before arachidonic acid treatment)

표 3에서 보는 바와같이 탱자 추출물 1.0%, 3.0%는 각각 25.1%, 30.2%의 염증억제율을 보였으며 부종 증가율로 유의차 검증시 탱자 추출물은 아라키돈산과 99%의 유의수준을 보였다.As shown in Table 3, 1.0% and 3.0% of the tanza extracts showed 25.1% and 30.2%, respectively. Inhibition of edema increased the tanza extract with arachidonic acid and 99%.

실험 4. 피부 1차 자극성시험(폐쇄첩포실험)Experiment 4. Primary Skin Irritation Test (Closed Wrap Test)

본 추출물 1.0% 및 소디움라우릴설페이트 0.08%를 함유한 수용액과 소디움라우릴설페이트 0.08% 수용액을 건강한 성인 남, 여 50명을 대상으로 등부위에 각 시료의 일정량(0.2g)을 24시간 첩포한 후 핀챔버를 제거하고 4시간 경과한 다음 육안으로 피부상태 변화를 판독하여 그 결과를 표 4에 나타내었다.An aqueous solution containing 1.0% of the extract and 0.08% of sodium lauryl sulfate and 0.08% of sodium lauryl sulfate were applied to a healthy adult male and female 50 people at 24 hours with a predetermined amount (0.2 g) of each sample on the back. 4 hours after the pin chamber was removed, the skin condition was visually read and the results are shown in Table 4.

피부 1차 자극성 시험결과Skin primary irritation test result 시 료sample 피시험지수Test Index 판정결과Judgment result 자극도Stimulus ++++ ++ +-+- -- 탱자 추출물 1.0%+소디움라우릴설페이트 0.08% 소디움라우릴설페이트 0.08% 정제수Tanza Extract 1.0% + Sodium Lauryl Sulfate 0.08% Sodium Lauryl Sulfate 0.08% Purified Water 50 50 5050 50 50 - 1 -- One - - 3 --3- 5 13 65 13 6 45 33 4445 33 44 0.10 0.40 0.120.10 0.40 0.12

※ 판정기준 - ; 홍반이나 특이한 현상없음※ Criteria - ; No erythema or unusual symptoms

+- ; 주위보다 약간 붉어짐            +-; Slightly redder than the surroundings

+ ; 주위보다 현저히 붉어짐            +; Significantly redder than the surroundings

++ ; 주위보다 심하게 붉어지고 부풀어오름            ++; Severe redness and swelling than the surroundings

Figure 111999009970904-pat00001
Figure 111999009970904-pat00001

표 4에서 보는 바와같이 탱자 추출물 1.0%는 소디움라우릴설페이트 0.08%의 자극을 정제수 정도의 자극 정도로 완화 시켜주는 항자극 효과가 우수하였다.As shown in Table 4, 1.0% of the tanza extract was excellent in the anti-irritant effect of alleviating the stimulation of sodium lauryl sulfate 0.08% to the degree of stimulation of purified water.

이와같이 항자극 효과가 우수하며 피부에 안전한 탱자 추출물을 일반적인 화장료 첨가제들을 사용하여 용도에 따라 유연화장수, 영양화장수, 영양크림 및 에센스, 세안용팩 등으로 제조될 수 있는데 이들을 제조하기 위한 제조예를 하기에 제시하였다.In this way, the tanza extract, which is excellent in anti-irritant effect and safe for skin, can be prepared according to the use of soft cosmetics, nourishing cosmetics, nourishing cream and essence, facial cleansing pack, etc. according to the use. Presented.

제조예 1Preparation Example 1

유연화장수Flexible Cosmetics 중량부Parts by weight 탱자 추출물 부틸렌글리콜 글리세린 히아루론산 폴리에틸렌 올레일에텔 폴리옥시에틸렌 경화피마자유 에탄올 방부제 향료 색소 정제수Tangerine Extract Butylene Glycol Glycerine Hyaluronic Acid Polyethylene Oleyl Ether Polyoxyethylene Cured Castor Oil Ethanol Preservative Perfume Pigment Purified Water 3.0 5.0 2.0 0.7 0.1 0.1 8.0 0.1 적량 적량 잔량3.0 5.0 2.0 0.7 0.1 0.1 8.0 0.1 appropriate quantity remaining quantity

제조예 2Preparation Example 2

영양화장수Nutrition 중량부Parts by weight 세토스테아릴알코올 자기유화형모노스테아린산 친유형모노스테아린산 밀납 스쿠알란 이소세틸옥타노에이트 디메틸폴리실록산 폴리솔베이트 60 솔비탄스테아레이트 농글리세린 프로필렌글리콜 카르복시폴리머 트리에탄올아민 탱자 추출물 방부제 향료 색소 정제수Cetostearyl Alcohol Self-emulsifying Monostearic Acid Lipophilic Monostearic Acid Beeswax Squalane Isocetyl Octanoate Dimethylpolysiloxane Polysorbate 60 Sorbitastearate Thickened Glycerin Propylene Glycol Carboxypolymer Triethanolamine Tanger Extract Preservatives 1.00 0.50 0.50 0.30 7.00 4.00 0.30 0.50 1.00 4.00 4.00 0.15 0.20 1.00 적량 적량 적량 잔량1.00 0.50 0.50 0.30 7.00 4.00 0.30 0.50 1.00 4.00 4.00 0.15 0.20 1.00 Accurate Proper Accurate

제조예 3Preparation Example 3

에센스essence 중량부Parts by weight 세토스테아릴알코올 자기유화형모노스테아린산 스쿠알란 네오펜틸글리콜 디카프레이트 디메틸폴리실록산 폴리솔베이트 60 폴리옥시에틸렌 경화피마자유 농글리세린 프로필렌글리콜 카르복시폴리머 트리에탄올아민 탱자 추출물 방부제 향료 색소 정제수Cetostearyl Alcohol Self-emulsifying Monostearic acid Squalane Neopentylglycol Dicaprate Dimethylpolysiloxane Polysorbate 60 Polyoxyethylene Cured Castor Oil Concentrated Glycerin Propylene Glycol Carboxypolymer Triethanolamine Tanga Extract Preservatives Flavors Pigments Purified Water 1.00 0.50 2.50 1.00 0.30 0.50 1.00 6.00 5.00 0.20 0.30 1.00 적량 적량 적량 잔량1.00 0.50 2.50 1.00 0.30 0.50 1.00 6.00 5.00 0.20 0.30 1.00 Accurate Proper Accurate

제조예 4Preparation Example 4

영양크림Nutrition Cream 중량부Parts by weight 세토스테아릴알코올 자기유화형모노스테아린산 친유형모노스테아린산 밀납 스쿠알란 이소세틸옥타노에이트 네오펜틸글리콜 디카프레이트 디메틸폴리실록산 폴리솔베이트 60 솔비탄스테아레이트 농글리세린 프로필렌글리콜 산탄검 트리에탄올아민 탱자 추출물 방부제 향료 색소 정제수Cetostearyl Alcohol Self-Emulsifying Monostearic Acid Lipophilic Monostearic Acid Beeswax Squalane Isocetyl Octanoate Neopentylglycol Dicaprate Dimethylpolysiloxane Polysorbate 60 Solbitan Stearate Thickened Glycerin Propylene Glycol Santhan Gum Triethanolamine Tangerine Extract Preservative Colorant 3.00 1.50 1.00 0.50 7.00 4.00 4.00 0.30 0.50 1.00 5.00 4.00 0.05 0.10 1.00 적량 적량 적량 잔량3.00 1.50 1.00 0.50 7.00 4.00 4.00 0.30 0.50 1.00 5.00 4.00 0.05 0.10 1.00 Accurate Proper balance

제조예 5Preparation Example 5

pack 중량부Parts by weight 폴리비닐알코올 산탄검 카르복시메칠셀루로오즈 폴리에틸렌 올레일에텔 폴리옥시에틸렌 경화피마자유 에탄올 농글리세린 프로필렌글리콜 트리에탄올아민 탱자 추출물 방부제 향료 색소 정제수Polyvinyl Alcohol Xanthan Gum Carboxymethyl Cellulose Polyethylene Oleyl Ether Polyoxyethylene Cured Castor Oil Ethanol Thickened Glycerin Propylene Glycol Triethanolamine Tanga Extract Preservatives Flavored Colors Purified Water 5.00 0.03 0.05 0.10 0.10 6.00 4.00 3.00 0.10 1.00 적량 적량 적량 잔량5.00 0.03 0.05 0.10 0.10 6.00 4.00 3.00 0.10 1.00 Proper Proceeds Proceeds

상기와 같이 제조된 화장료 조성물들은 유효성분으로 함유된 탱자 추출물에 의해 우수한 항자극 효과를 갖는다.Cosmetic compositions prepared as described above has an excellent anti-irritant effect by the tanza extract contained as an active ingredient.

Claims (2)

탱자 추출물 유효성분으로 함유하는 항자극용 화장료 조성물.Anti-irritant cosmetic composition containing as an active ingredient tanza extract. 제 1항에 있어서, The method of claim 1, 상기 화장료 조성물이 탱자 추출물을 0.001 내지 20.0 중량부로 포함하는 것을 특징으로 하는 항자극용 화장료 조성물.The cosmetic composition is an anti-irritant cosmetic composition, characterized in that it comprises a tanza extract in an amount of 0.001 to 20.0 parts by weight.
KR1019990034915A 1999-08-23 1999-08-23 Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients KR100561780B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990034915A KR100561780B1 (en) 1999-08-23 1999-08-23 Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990034915A KR100561780B1 (en) 1999-08-23 1999-08-23 Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients

Publications (2)

Publication Number Publication Date
KR20010018805A KR20010018805A (en) 2001-03-15
KR100561780B1 true KR100561780B1 (en) 2007-04-12

Family

ID=19608267

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990034915A KR100561780B1 (en) 1999-08-23 1999-08-23 Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients

Country Status (1)

Country Link
KR (1) KR100561780B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101045579B1 (en) 2010-11-16 2011-06-30 장영웅 Cosmetic composition for white using tritoliate orange and its manufacturing method

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100469006B1 (en) * 2002-06-21 2005-02-02 강광일 Process for preparing health beverage
KR100537492B1 (en) * 2002-06-28 2005-12-19 이영근 Novel natural compound having antibacterial activity
KR100489035B1 (en) * 2002-11-01 2005-05-11 김선호 The powdered cleanser and the manufacture process of powdered cleanser
FR2903310B1 (en) * 2006-07-04 2008-10-17 Lvmh Rech COSMETIC COMPOSITION CONTAINING AN EXTRACT OF LIMNOCITRUS LITTORALIS
KR100830851B1 (en) * 2006-09-06 2008-05-20 재단법인 제주하이테크산업진흥원 Poncirus polyandra extracts having whitening activity and anti-inflammatory activity
KR100829717B1 (en) * 2006-09-14 2008-05-15 주식회사 코리아나화장품 Astringent Cosmetic Composition Comprising the Extract from the Fruit of Poncirus trifoliata as Active Ingredient
KR100920898B1 (en) * 2007-10-30 2009-10-12 주식회사 코리아나화장품 Pore astringent cosmetic composition containing Poncirus trifoliate extract and hydrogenated phosphatidylcholine
KR102088964B1 (en) * 2018-07-18 2020-03-13 주식회사 아미코스메틱 A cosmetic composition comprising poncirus fructus extract
KR102581571B1 (en) * 2021-02-22 2023-09-25 주식회사 네이처팩토리 Cosmetic composition containing the mixed extract of Polygonum aviculare, Poncirus trifoliata fruit and Hovenia dulcis fruit
KR102670748B1 (en) * 2023-09-05 2024-05-30 한국콜마주식회사 Cosmetic composition for the improvement of skin damage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101045579B1 (en) 2010-11-16 2011-06-30 장영웅 Cosmetic composition for white using tritoliate orange and its manufacturing method

Also Published As

Publication number Publication date
KR20010018805A (en) 2001-03-15

Similar Documents

Publication Publication Date Title
Potluri et al. A review on herbs used in anti-dandruff shampoo and its evaluation parameters
WO2004016236A1 (en) Cosmetics
CN114929195A (en) Composition containing plant extract
JP3407935B2 (en) External preparation for skin
KR102142311B1 (en) Skin external composition comprising tangeretin
KR100561780B1 (en) Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients
KR20150050310A (en) Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same
WO2012172199A1 (en) Composition based on camellia japonica and polygonum hydropiper for protecting the skin
JP4495406B2 (en) Sendangusa plant extract-containing composition
KR100776346B1 (en) A composition comprising an extract eclipta prostrata l., rehmannia glutinosa liboschtz var. purpurea makino, polygonum multiflorium thunb. and pinellia ternata breit. showing anti-dandruff and anti-inflammatory activity
KR101078888B1 (en) A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof
KR101732906B1 (en) Skin care and atopic dermatitis cosmetic compositions containing asiatic pennywort extract, magnolia bark extract, hiba arborvitae branch extract, eucalyptus oil and borage seed oil
KR102300581B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR100702327B1 (en) Cosmetic material including extract of camellia flower for skin abirritation
JPH09227353A (en) Skin whitening cosmetic composition
KR102257448B1 (en) Cosmetic composition containing black kelp
KR102073945B1 (en) Cosmetic composition for improvement of skin itching and moisturizing with the extract of Corydalis platycarpa
KR101127393B1 (en) Composition for preventing or alleviating atopic dermatitis, and process for preparing the same
KR20020001911A (en) Cosmetic composition containing portulaca oleracea L. extract for anti-inflammation and anti-irritation
KR20170137412A (en) Composition for improving skin condition comprising herb extracts mixture
KR102070316B1 (en) Composition for treating or preventing oral diseases comprising natural complex
JP4716497B2 (en) External preparation for skin and hyaluronidase inhibitor
KR102076179B1 (en) A cosmetic composition for alleviating skin irritation by vitamin c containing a mixed extract of iris lactea and doellingeria scabra
CN107260792A (en) The composition of mouth disease is prevented or treated to being used for comprising natural complex
JP5325727B2 (en) Sendangusa plant extract-containing composition

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121221

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20131230

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20141226

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20151229

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20161227

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20180111

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20190103

Year of fee payment: 14

EXPY Expiration of term